Skip to content

Clinical trials

Phase 3 Lymphoma, B-Cell trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Phase: Phase 3 Country / region: China Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20092
20111
20131
20151
20191
20202
20215
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting5
Recruiting2
Unknown status2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Loxo Oncology, Inc.5
Novartis Pharmaceuticals2
Acerta Pharma BV1
BeOne Medicines1
Fudan University1
Gustave Roussy, Cancer Campus, Grand Paris1
Hoffmann-La Roche1
Janssen Research & Development, LLC1
Millennium Pharmaceuticals, Inc.1
Ruijin Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell17
Lymphoma, Non-Hodgkin8
Lymphoma6
Hematologic Diseases5
Lymphoma, Large B-Cell, Diffuse5
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoma, Mantle-Cell3
Burkitt Lymphoma1
Cardiotoxicity1
Hematologic Neoplasms1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.